Review article: Oxidative stress as a pathogenic factor in inflammatory bowel disease - Radicals or ridiculous?

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 12, 2002, Pages 1997-2015

  Kruidenier, L ^a,b   Verspaget, H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; CHELATING AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; DNA; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE LIPID; METAL; METALLOTHIONEIN; NITRIC OXIDE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; CELL CYCLE; COLON BIOPSY; CROHN DISEASE; DETOXIFICATION; DIETARY INTAKE; ENTERITIS; ENZYME ACTIVITY; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANTIOXIDANTS; HUMANS; INFLAMMATORY BOWEL DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 0036909108     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01378.x     Document Type: Review

References (264)

1. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 2nd Edn. Oxford; Clarendon Press, 1989.
2. Halliwell B. Antioxidants in human health and disease. Ann Rev Nutr 1996; 16: 33-50.
3. McCord JM. The evolution of free radicals and oxidative stress. Am J Med 2000; 108: 652-9.
4. Vlessis AA, Goldman RK, Trunkey DD. New concepts in the pathophysiology of oxygen metabolism during sepsis. Br J Surg 1995; 82: 870-6.
5. Chapple ILC. Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases. J Clin Pathol: Mol Pathol 1996; 49: M247-55.
6. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-8.
7. Delanty N, Dichter MA. Oxidative injury in the nervous system. Acta Neurol Scand 1998; 98: 145-53.
8. Saugstad OD. Chronic lung disease: The role of oxidative stress. Biol Neonate 1998; 74S: 21-8.
9. Reid GM, Tervit H. Sudden infant death syndrome: Oxidative stress. Med Hypotheses 1999; 52: 577-80.
10. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315-23.
11. MacNee W. Oxidants/antioxidants and COPD. Chest 2000; 117; 303S-317S.
12. Robberecht W. Oxidative stress in amyotrophic lateral sclerosis. J Neurol 2000; 247S: I/1-I/6.
13. Rosen GM, Pou S, Ramos CL, et al. Free radicals and phagocytic cells. FASEB J 1995; 9: 200-9.
14. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: Oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007-17.
15. Babior BM, Phagocytes and oxidative stress. Am J Med 2000; 109: 33-44.
16. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-60.
17. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
18. Panes J, Granger N. Neutrophils generate oxygen free radicals in rat mesenteric microcirculation after abdominal irradiation. Gastroenterology 1996; 111: 981-9.
19. Fridovich I. Superoxide radical and superoxide dismutases. Ann Rev Biochem 1995; 64: 97-112.
20. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17: 3-8.
21. Richter C, Schweizer M. Oxidative stress in mitochondria. In: Scandalios JG. ed. Oxidative Stress and the Molecular Biology of Antioxidant Defenses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1997; 169-200.
22. Kooij A. A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase. Histochem J 1994; 26: 889-915.
23. Wakefield A, Snakey E, Dhillon A, et al. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 1989; 2: 1057-62.
24. Ma TY, Hollander D, Freeman D, et al. Oxygen free radical injury of IEC-18 small intestinal epithelial cell monolayers. Gastroenterology 1991; 100: 1533-43.
25. Baker SS, Campbell CL. Rat enterocyte injury by oxygen-dependent processes. Gastroenterology 1991; 101: 716-20.
26. Mulier B, Rahman I, Watchorn T, et al. Hydrogen peroxide-induced epithelial iniury: The protective role of intracellular nonprotein thiols (NPSH). Eur Respir J 1998; 11: 384-91.
27. Wardman P, Candelas LP, Fenton chemistry: An introduction. Radiat Res 1996; 145: 523-31.
28. Tsuruta T, Tani K, Hoshika A, et al. Myeloperoxidase gene expression and regulation by myeloid growth factors in normal and leukemic cells. Leuk Lymphoma 1999; 32: 257-67.
29. Cohen AB, Chenoweth DE, Hugli TE. The release of elastase, myeloperoxidase, and lysozyme from human alveolar macrophages. Am Rev Respir Dis 1982; 126: 241-7.
30. King CC, Jefferson MM, Thomas EL. Secretion and inactivation of myeloperoxidase by isolated neutrophils. J Leuk Biol 1997; 61: 293-302.
31. Schraufstätter IU, Browne K, Harris A, et al. Mechanisms of hypochlorite injury of target cells. J Clin Invest 1990; 85: 554-62.
32. Carr AC, Winterbourn CC. Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid. Biochem J 1997; 327: 275-81.
33. Zavodnik IB, Lapshina EA, Zavodnik LB, et al. Hypochlorous acid damages erythrocyte membrane proteins and alters lipid bilayer structure and fluidity. Free Rad Biol Med 2001; 30: 363-9.
34. Vissers MCM, Thomas C. Hypochlorous acid disrupts the adhesive properties of subendothelial matrix. Free Rad Biol Med 1997; 23: 401-11.
35. Tatsumi T, Fliss H, Hypochlorous acid and chloramines increase endothelial permeability: Possible involvement of cellular zinc. Am J Physiol 1994; 267: H1597-1607.
36. Yan LJ, Traber MG, Kobuchi H, et al. Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch Biochem Biophys 1996; 327: 330-4.
37. Lubec G, The hydroxyl radical: From chemistry to human disease. J Invest Meal 1996; 44: 324-46.
38. Tabatabaie T, Ports JD, Floyd RA, Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase. Arch Biochem Biophys 1996; 336: 290-6.
39. Takeuchi T, Nakajima M, Morimoto K, Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis 1996; 17: 1543-8.
40. Halliwell B, Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: Measurement, mechanism and the effects of nutrition. Murat Res 1999; 443: 37-52.
41. Kehrer JP, The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 149: 43-50.
42. Yim MB, Chock PB, Stadtman ER, Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc Natl Acad Sci USA 1990; 87: 5006-10.
43. Candelas LP, Patel KB, Stratford MRL, et al. Free hydroxyl radicals are formed on reaction between neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett 1993; 333: 151-3.
44. Candeias LP, Stratford MR, Wardman P. Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron (II) complex. Free Rad Res 1994; 20; 241-9.
45. Nappi AJ, Vass E, Hydroxyl radical formation resulting from the interaction of nitric oxide and hydrogen peroxide. Biochim Biophys Acta 1998; 1380: 55-63.
46. Grisham MB, Jourd'heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: Implications in inflammation. Am J Physiol 1999; 276; G315-21.
47. Kubes P, McCafferty D-M. Nitric oxide and intestinal inflammation. Am J Med 2000; 109: 150-8.
48. Lefer AM, Lefer DJ, Nitric oxide. II. Nitric oxide protects in intestinal inflammation. Am J Physiol 1999; 276: G572-75.
49. Wink DA, Cook JA, Pacelli R, et al. Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett 1995; 82/83: 221-6.
50. Kim H, Kim K. Effect of nitric oxide on hydrogen peroxide-induced damage in isolated rabbit gastric glands. Pharmacology 1998; 57: 323-30.
51. Scivittaro V, Boggs S, Mohr S, et al. Peroxynitrite protects raw 264.7 macrophage from lipopolysaccharide/interferon-γ-induced cell death. Biochem Biophys Res Commun 1997; 241: 37-42.
52. Binion DG, Rafiee P, Ramanuiam KS, et al. Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Rad Biol Med 2000; 29: 881-8.
53. Packer MA, Porteous CM, Murphy MP. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol Int 1996; 40: 527-34.
54. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997; 94: 6954-8.
55. Reiter CD, Teng R-J, Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 2000; 275: 32 460-6.
56. Murphy MP, Packer MA, Scarlett JL, et al. Peroxynitrite: A biologically significant oxidant. Gen Pharmacol 1998; 31: 179-86.
57. Marla SS, Lee J, Groves JT. Peroxynitrite rapidly permeates phospholipid membranes. Proc Natl Acad Sci USA 1997; 94: 14 243-8.
58. 2+-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch Biochem Biophys 1997; 345: 243-50.
59. Bauer ML, Beckman JS, Bridges RJ, et al. Peroxynitrite inhibits sodium uptake in rat colonic membrane vesicles. Biochim Biophys Acta 1992; 1104: 87-94.
60. Greenacre S, Ridger V, Wilsoncroft P, et al. Peroxynitrite: A mediator of increased microvascular permeability? Clin Exp Pharmacol Physiol 1997; 24: 880-2.
61. Ródenas J, Mitjavila MT, Carbonell T. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes. Am J Physiol 1998; 274: C827-30.
62. Xia Y, Dawson VL, Dawson TM, et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996; 93: 6770-4.
63. Arteel GE, Briviba K, Sies H, Protection against peroxynitrite. FEBS Lett 1999; 445: 226-30.
64. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-28.
65. Ohyashiki T, Ohtsuka T, Mohri T. A change in the lipid fluidity of the porcine intestinal brush-border membranes by lipid peroxidation. Studies using pyrene and fluorescent stearic acid derivatives. Biochim Biophys Acta 1986; 861: 311-8.
66. Jourd'Heuil D, Vaananen P, Meddings JB. Lipid peroxidation of the brush-border membrane; membrane physical properties and glucose transport. Am J Physiol 1993; 264: G1009-15.
67. Chen JJ, Bertrand H, Yu BP, Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Rad Biol Med 1995; 19: 583-90.
68. Aw TY. Determinants of intestinal detoxification of lipid hydroperoxides. Free Rad Res 1998; 28: 637-46.
69. Curzio M, Esterbauer H, Poli G, et al. Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React 1987; 9: 295-306.
70. Jayatilleke A, Shaw S, Stimulation of monocyte interleukin-8 by lipid peroxidation products: A mechanism for alcohol-induced liver injury. Alcohol 1998; 16: 119-23.
71. Hogg N, Kalyanaraman B, Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1999; 1411: 378-84.
72. Stadtman ER, Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997; 10: 485-94.
73. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324: 1-18.
74. Ischiropoulos H, Al-Mehdi AB. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 1995; 364: 279-82.
75. Ischiropoulos H. Biological tyrosine nitration: A pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356: 1-11.
76. Ischiropoulos H, Zhu L, Chert J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992; 298: 431-7.
77. MacMillan-Crow LA, Crow JP, Kerby JD, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA 1996; 93: 11 853-8.
78. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391: 393-7.
79. Sampson JB, Ye Y, Rosen H, et al. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys 1998; 356: 207-13.
80. Henle ES, Linn S, Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide. J Biol Chem 1997; 272: 19 095-8.
81. Yakes FM, Van Houten B, Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997; 94: 514-9.
82. - radicals in aqueous solution. J Phys Chem Ref Data 1985; 14: 1041-100.
83. Cuzzocrea S, Caputi AP, Zingarelli B. Peroxynitrite-mediated DNA strand breakage activates poly(ADP-ribose) synthethase and causes cellular energy depletion in carrageenan-induced pleurisy. Immunology 1998; 93: 96-101.
84. Kennedy M, Denenberg AG, Szabó C, et al. Poly(ADP-ribose) synthethase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998; 114: 510-8.
85. Nguyen T, Brunson D, Crespi CL, et al. DNA damage and mutation in human cells exposed to nitric oxide in vivo. Proc Natl Acad Sci USA 1992; 89: 3030-4.
86. 2-mediated DNA strand breaks and 8-hydroxydeoxyguanosine formation. Enhancement by copper, zinc superoxide dismutase. Biochim Biophys Acta 1997; 1336: 263-8.
87. Meneghini R, Iron homeostasis, oxidative stress, and DNA damage. Free Rad Biol Med 1997; 23: 783-92.
88. Chubatsu LS, Meneghini R. Metallothionein protects DNA from oxidative damage. Biochem J 1993; 291: 193-8.
89. Tsujikawa K, Imai T, Kakutani M, et al. Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes. FEBS Lett 1991; 283: 239-42.
90. McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett 1998; 99: 157-68.
91. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Rad Biol Med 2000; 29: 323-33.
92. Gardner AM, Xu F-H, Fady C, et al. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Rad Biol Med 1997; 22: 73-83.
93. Sandoval M, Liu X, Mannick EE, et al. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997; 113: 1480-8.
94. Zucker B, Hanusch J, Bauer G. Glutathione depletion in fibroblasts is the basis for apoptosis-induction by endogenous oxygen species. Cell Death Diff 1997; 4: 388-95.
95. Clément M-V, Ponton A, Pervaiz S. Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett 1998; 440: 13-8.
96. Bosca L, Hortelano S. Mechanisms of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators. Cell Signal 1999; 11: 239-44.
97. Warren MC, Bump EA, Medeiros D, et al. Oxidative stress-induced apoptosis of endothelial cells. Free Rad Biol Med 2000; 29: 537-47.
98. Baker AF, Briehl MM, Dorr R, et al. Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Diff 1996; 3: 207-13.
99. Akahoshi T, Namai R, Sekiyama N, et al. Rapid induction of neutrophil apoptosis by sulfasalazine: Implications of reactire oxygen species in the apoptotic process. J Leuk Biol 1997; 62: 817-26.
100. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J. et al. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-α-induced apoptosis of rat mesangial cells. J Biol Chem 2000; 275: 12 684-91.
101. Ottonello L, Frumento G, Arduino N, et al. Immune complex stimulation of neutrophil apoptosis: Investigating the involvement of oxidative and nonoxidative pathways. Free Rad Biol Med 2001; 30: 161-9.
102. Shibuya H, Ohkohchi N, Tsukamoto S, et al. Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver. Hepatology 1997; 26: 113-20.
103. Nishikawa M, Kakemizu N, Ito T, et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-κB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999; 20: 189-98.
104. Martínez J, Moreno JJ. Influence of superoxide radical and hydrogen peroxide on arachidonic acid mobilization. Arch Biochem Biophys 1996; 336: 191-8.
105. Klyubin IV, Kirpichnikova KM, Gamaley IA. Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils. Eur J Cell Biol 1996; 70: 347-51.
106. Johnston B, Kanwar S, Kubes P. Hydrogen peroxide induces leukocyte rolling: Modulation by endogenous antioxidant mechanisms including NO. Am J Physiol 1996; 271: H614-21.
107. Monte M, Davel LE, Sacerdote de Lustig E. Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur J Cancer 1997; 33: 676-82.
108. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999; 11: 1-14.
109. Rogler G, Brand K, Vogl D, et al. Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998; 115: 357-69.
110. Barnes PJ, Karin M. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-71.
111. Janssen-Heininger YMW, Macara I, Mossman BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-κB. Requirement of Ras/mitogen-activated protein kinases in the activation of NF-κB by oxidants. Am J Respir Cell Mol Biol 1999; 20: 942-52.
112. Meier B, Radeke HH, Selle S, et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 1989; 263: 539-45.
113. Adamson GM, Billings RE. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys 1992; 294: 223-9.
114. Lo YY, Conquer JA, Grinstein S, et al. Interleukin-1 beta induction of c-fos and collagenase expression in articular chondrocytes: Involvement of reactive oxygen species. J Cell Biochem 1998; 69: 19-29.
115. Meyer M, Pahl HL, Baeuerle PA. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem Biol Interact 1994; 91: 91-100.
116. Janssen-Heininger YMW, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Rad Biol Med 2000; 28: 1317-27.
117. Schoonbroodt S, Legrand-Poels S, Best-Belpomme M, et al. Activation of the NF-κB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem J 1997; 321: 777-85.
118. Pender SL, Tickle SP, Docherty AJP, et al. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997; 158: 1582-90.
119. Baugh MD, Perry MJ, Hollander AP, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999; 117: 814-22.
120. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997; 7: 159-78.
121. Wenk J, Brenneisen P, Wlaschek M, et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 1999; 274: 25 869-76.
122. Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-9.
123. 2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Rad Biol Med 1997; 22: 515-24.
124. Frears ER, Zhang Z, Blake DR, et al. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 1996; 381: 21-4.
125. Fiocchi C, Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
126. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997; 18: 555-89.
127. Rumley AG, Paterson JR. Analytical aspects of antioxidants and free radical activity in clinical biochemistry. Ann Clin Biochem 1998; 35: 181-200.
128. Briggs RT, Robinson JM, Karnovsky ML, et al. Superoxide production by polymorphonuclear leukocytes. A cytochemical approach. Histochemistry 1986; 84: 371-8.
129. Oshitani N, Kitano A, Okabe H, et al. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut 1993; 34: 936-8.
130. Dannenberg AM, Schofield BH, Rao JB, et al. Histochemical demonstration of hydrogen peroxide production by leukocytes in fixed-frozen tissue sections of inflammatory lesions. J Leuk Biol 1994; 56: 436-43.
131. Karnovsky MJ. Cytochemistry and reactive oxygen species: A retrospective. Histochemistry 1994; 102: 15-27.
132. Frank J, Pompella A, Biesalski HK. Histochemical visualization of oxidant stress. Free Rad Biol Med 2000; 29: 1096-105.
133. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 1980; 38: 161-70.
134. Halliwell B, Grootveld M, Gutteridge JMC. Methods for the measurement of hydroxyl radicals in biochemical systems: Deoxyribose degradation and aromatic hydroxylation. Methods Biochem Res 1988; 33: 59-90.
135. Nims RW, Cook JC, Krishna MC, et al. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 1996; 268: 93-105.
136. Mueller S. Sensitive and non-enzymatic measurement of hydrogen peroxide in biological systems. Free Rad Biol Med 2000; 29: 410-5.
137. Togashi H, Shinzawa H, Matsuo T, et al. Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging. Free Rad Biol Med 2000; 28: 846-53.
138. -. Free Rad Biol Med 1993; 15: 447-51.
139. -), superoxide dismutases, and related matters. J Biol Chem 1997; 272: 18 515-7.
140. Keshavarzian A, Sedghi S, Kanofsky J, et al. Excessive production of reactive oxygen metabolites by inflamed colon: Analysis by chemiluminescence probe. Gastroenterology 1992; 103: 177-85.
141. Simmonds NJ, Allen RE, Stevens TRJ, et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992; 103: 186-96.
142. Sedghi S, Fields JZ, Klamut M, et al. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 1993; 34: 1191-7.
143. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-86.
144. Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 718-23.
145. Herulf M, Ljung T, Hellström PM, et al. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998; 33: 164-9.
146. Rachmilewitz D, Eliakim R, Ackerman Z, et al. Direct determination of colonic nitric oxide level - A sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol 1998; 93: 409-12.
147. Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-40.
148. Godkin AJ, De Belder AJ, Villa L, et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26: 867-72.
149. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-85.
150. Ikeda I, Kasajima T, Ishiyama S, et al. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 1997; 92: 1339-41.
151. McLaughlan JM, Seth R, Vautier G, et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997; 181: 87-92.
152. Dijkstra G, Moshage H, Van Dullemen HM, et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998; 186: 416-21.
153. Gupta SK, Fitzgerald JF, Chong SKF, et al. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population. Am J Gastroenterol 1998; 93: 795-8.
154. Kimura H, Hokari R, Miura S, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998; 42: 180-7.
155. Kolios G, Rooney N, Murphy CT, et al. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: Modulation by T lymphocyte derived cytokines. Gut 1998; 43: 56-63.
156. Leonard N, Bishop AE, Polak JM, et al. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol 1998; 51: 750-3.
157. Zhang X-J, Thompson JH, Mannick EE, et al. Localization of inducible nitric oxide synthase mRNA in inflamed gastrointestinal mucosa by in situ reverse transcriptase-polymerase chain reaction. Nitric Oxide 1998; 2: 187-92.
158. Gaginella TS, Kachur JF, Tamai H, et al. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology 1995; 109: 2019-28.
159. Kruidenier L, Verspaget HW. Antioxidants and mucosa protectives: Realistic therapeutic options in inflammatory bowel disease? Med Inflamm 1998; 7: 157-62.
160. McKenzie SJ, Baker MS, Buffinton GD. et al. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996; 98: 136-41.
161. De Zwart LL, Meerman JHN, Commandeur JNM, et al. Biomarkers of free radical damage. Applications in experimental animals and in humans. Free Rad Biol Med 1999; 26: 202-26.
162. Winterbourn CC, Kettle AJ. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Rad Biol Med 2000; 29: 403-9.
163. Chiarpotto E, Scavazza A, Leonarduzzi G, et al. Oxidative damage and transforming growth factor beta 1 in pretumoral and tumoral lesions of human intestine. Free Rad Biol Med 1997; 22: 889-94.
164. Selley ML. Determination of the lipid peroxidation product 4-hydroxy-2-nonenal in clinical samples by gas chromatography - Negative-ion chemical ionisation mass spectrometry of the O-pentafluorobenzyl oxime. J Chromatogr B: Biomed Sci Appl 1997; 691: 263-8.
165. Sedghi S, Keshavarzian A, Klamut M, et al. Elevated breath ethane levels in active ulcerative colitis: Evidence for excessive lipid peroxidation. Am J Gastroenterol 1994; 89: 2217-21.
166. Pelli MA, Trovarelli G, Capodicasa E, et al. Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis Colon Rectum 1999; 42: 71-6.
167. Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Rad Biol Med 2000; 28: 880-6.
168. Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Rad Res 2000; 33: S99-108.
169. Levine AD. Apoptosis: Implications for inflammatory bowel disease. Inflamm Bowel Dis 2000; 6: 191-205.
170. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 1993; 46: 118-22.
171. Iwamoto M, Koji T, Makiyama K, et al. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996; 180: 152-9.
172. Sträter J, Wellisch I, Riedl S, et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis. Gastroenterology 1997; 113: 160-7.
173. Boirivant M, Marini M, Di Felice G, et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116: 557-65.
174. Ina K, Itoh J, Fukushima K, et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999; 163: 1081-90.
175. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000; 6: 583-8.
176. Brannigan AE, O'Connell PR, Hurley H, et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 2000; 13: 361-6.
177. Aruoma OI. Free radicals: Dietary advantages and disadvantages. In: Scandalios JG. ed. Oxidative Stress and the Molecular Biology of Antioxidant Defenses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press. 1997: 841-60.
178. Harding JJ, Blakytny R, Ganea E. Glutathione in disease. Biochem Soc Trans 1996; 24: 881-3.
179. Xu Y, Jones BE, Neufeld DS, et al. Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor α toxicity. Gastroenterology 1998; 115: 1229-37.
180. Davis SR, Cousins RJ. Metallothionein expression in animals: A physiological perspective on function. J Nutr 2000; 130: 1085-8.
181. Thornalley PJ, Vašák M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 1985; 827: 36-44.
182. Thomas JP, Bachowski GJ, Girotti AW. Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins. Biochim Biophys Acta 1986; 884: 448-61.
183. Cai L, Klein JB, Kang YJ. Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage. J Biol Chem 2000; 275; 38 957-60.
184. Rossman TG, Goncharova EI. Spontaneous mutagenesis in mammalian cells is caused mainly by oxidative events and can be blocked by antioxidants and metallothionein. Mutat Res 1998; 402: 103-10.
185. Deng DX, Cai L, Chakrabarti S, et al. Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein. Toxicology 1999; 134: 39-49.
186. Clarkson JP, Elmes ME, Jasani B, et al. Histological demonstration of immunoreactive zinc metallothionein in liver and ileum of rat and man. Histochem J 1985; 17: 343-52.
187. Elmes MĖ, Clarkson JP, Jasani B. Histological demonstration of immunoreactive metallothionein in rat and human tissues. Experientia 1987; 52: 533-7.
188. Janssen AML, Van Duijn W, Oostendorp-Van de Ruit MM, et al. Metallothionein in human gastrointestinal cancer. J Pathol 2000; 192: 293-300.
189. Sato M, Sasaki M, Hojo H. Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-α and interleukin-6. Arch Biochem Biophys 1995; 316: 738-44.
190. Fliss H, Ménard M. Oxidant-induced mobilization of zinc from metallothionein. Arch Biochem Biophys 1992; 293: 195-9.
191. McCord JM, Fridovich I. Superoxide dismutase: An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-55.
192. Klug D, Rabani J, Fridovich I. A direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis. J Biol Chem 1972; 247: 4839-42.
193. Crapo JD, Oury T, Rabouille C, et al. Copper zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA 1992; 89: 10 405-9.
194. Oury TD, Chang LY, Day BJ, et al. Compartmentalization of radical reactions. In: Davies KJA, Ursini FS, eds. The Oxygen Paradox. Padova: CLEUP University Press, 1995; 195-207.
195. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 1984; 222: 649-55.
196. Pietarinen-Runtti P, Lakari E, Raivio KO, et al. Expression of antioxidant enzymes in human inflammatory cells. Am J Physiol 2000; 278: C118-25.
197. Offer T, Russo A, Samuni A. The pro-oxidative activity of SOD and nitroxide SOD mimics. FASEB J 2000; 14: 1215-23.
198. Kedziora J, Bartosz G, Down's syndrome: A pathology involving the lack of balance of reactive oxygen species. Free Rad Biol Med 1988; 4: 317-30.
199. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
200. Whittaker JW. Manganese superoxide dismutase. Metal Ions in Biological Systems 2000; 37: 587-611.
201. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995; 11: 376-81.
202. Reaume AG, Elliott JT, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 13: 43-7.
203. Carlsson LM, Jonsson J, Edlund T, et al. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995; 92: 6264-8.
204. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982; 79: 7634-8.
205. Oury TD, Chang L-Y, Marklund SL. et al. Immunocyto-chemical localization of extracellular superoxide dismutase in human lung. Lab Invest 1994; 70: 889-98.
206. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase: A regulator of nitric oxide bioavailability. Lab Invest 1996; 75: 617-36.
207. Singh AK, Dhaunsi GS, Gupta MP, et al. Demonstration of glutathione peroxidase in rat liver peroxisomes and its intraorganellar distribution. Arch Biochem Biophys 1994; 315: 331-8.
208. Tham DM, Whitin JC, Kim KK, et al. Expression of extracellular glutathione peroxidase in human and mouse gastrointestinal tract. Am J Physiol 1998; 275: G1463-71.
209. 2. Arch Biochem Biophys 1981; 210: 505-16.
210. McCay P, Gibson D, Fong K, et al. Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes. Biochim Biophys Acta 1976; 431: 459-68.
211. Sies H, Sharov VS, Klotz L-O, et al. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 1997; 272: 27 812-7.
212. Hata Y, Kawabe T, Hiraishi H, et al. Antioxidant defenses of cultured colonic epithelial cells against reactive oxygen metabolites. Eur J Pharmacol 1997; 321: 113-9.
213. 2 or ultraviolet B light. Arch Dermatol Res 1998; 290: 113-8.
214. Seo SJ, Kim HT, Cho G, et al. Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene. Gene 1996; 178: 177-85.
215. Visner GA, Dougall WC, Wilson JM, et al. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J Biol Chem 1990; 265: 2856-64.
216. Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 1992; 267: 6696-701.
217. Valentine JF, Nick HS, Acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines. Gastroenterology 1992; 103: 905-12.
218. Isoherranen K, Peltola V, Laurikainen L, et al. Regulation of copper/zinc and manganese superoxide dismutase by UVB irradiation, oxidative stress and cytokines. J Photochem Photobiol B: Biol 1997; 40: 288-93.
219. Siemankowski LM, Morreale J, Briehl MM, Antioxidant defenses in TNF-treated MCF-7 cells: Selective increase in MnSOD. Free Rad Biol Med 1999; 26: 919-24.
220. Shull S, Heintz NH, Periasamy M, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991; 266: 24 398-403.
221. Strålin P, Marklund SL. Effects of oxidative stress on expression of extracellular superoxide dismutase. CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts. Biochem J 1994; 298: 347-52.
222. Röhrdanz E, Kahl R. Alterations of antioxidant enzyme expression in response to hydrogen peroxide. Free Rad Biol Med 1998; 24: 27-38.
223. Pereira B, Costa Rosa LFBP, Safi DA, et al. Hormonal regulation of superoxide dismutase, catalase, and glutathione peroxidase activities in rat macrophages. Biochem Pharmacol 1995; 50: 2093-8.
224. Ho YS, Howard AJ, Crapo JD. Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. Am J Respir Cell Mol Biol 1991; 4: 278-86.
225. Zhang N. Characterization of the 5′ flanking region of the human MnSOD gene. Biochem Biophys Res Commun 1996; 220: 171-80.
226. Kiningham KK, Xu Y, Daosukho C, et al. Nuclear factor κB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem J 2001; 353: 147-56.
227. Warner BB, Stuart L, Gebb S, et al. Redox regulation of manganese superoxide dismutase. Am J Physiol 1996; 271: L150-8.
228. Jackson RM, Parish G, Helton ES. Peroxynitrite modulates MnSOD gene expression in lung epithelial cells. Free Rad Biol Med 1998; 25: 463-72.
229. Warner BB, Burhans MS, Clark JC, et al. Tumor necrosis factor-α increases Mn-SOD expression: Protection against oxidant iniury. Am J Physiol 1991; 260: L296-301.
230. Kuratko CN, Constante BJ. Linoleic acid and tumor necrosis factor-α increase manganese superoxide dismutase activity in intestinal cells. Cancer Lett 1998; 130: 191-6.
231. Harris CA, Derbin KS, Hunte-McDonough B, et al. Manganese superoxide dismutase is induced by IFN-γ in multiple cell types. Synergistic induction by IFN-γ and tumor necrosis factor or IL-1. J Immunol 1991; 147: 149-54.
232. Tian L, White JE, Lin H-Y. et al. Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Am J Physiol 1998; 275: C740-7.
233. Valentine JF, Nick HS. Glucocorticoids repress basal and stimulated manganese superoxide dismutase levels in rat intestinal epithelial cells. Gastroenterology 1994; 107: 1662-70.
234. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem 1982; 257: 5751-4.
235. Pigeolet E, Corbisier P, Houbion A, et al. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990; 51: 283-97.
236. Kim YS, Han S. Nitric oxide protects Cu. Zn-superoxide dismutase from hydrogen peroxide-induced inactivation. FEBS Lett 2000; 479: 25-8.
237. Aruoma OI, Halliwell B. Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem J 1987; 248: 973-6.
238. Asahi M, Fujii J, Suzuki K, et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem 1995; 270: 21 035-9.
239. Yamakura F, Taka H, Fujimura T, et al. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998; 273: 14 085-9.
240. Padmaja S, Squadrito GL, Pryor WA. Inactivation of glutathione peroxidase by peroxynitrite. Arch Biochem Biophys 1998; 349: 1-6.
241. Michiels C, Raes M, Toussaint O, et al. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Rad Biol Med 1994; 17: 235-48.
242. Moysan A, Marquis I, Gaboriau F, et al. Ultraviolet A-induced lipid peroxidation and antioxidant defense systems in cultured human skin fibroblasts. J Invest Dermatol 1993; 100: 692-8.
243. Picardo M, Grammatico P, Rocella F, et al. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 1996; 107: 322-6.
244. Gaetani P, Pasqualin A, Rodriguez y Baena R, et al. Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 1998; 89: 748-54.
245. Iantomasi T, Marraccini P, Favilla F, et al. Glutathione metabolism in Crohn's disease. Biochem Med Metab Biol 1994; 53: 87-91.
246. Buffinton GD, Doe WF, Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Rad Biol Med 1995; 19: 911-8.
247. Ruan EA, Rao S, Burdick JS, et al. Glutathione levels in chronic inflammatory disorders of the human colon. Nutr Res 1997; 17: 463-73.
248. Holmes EW, Yong SL, Eiznhamer D, et al. Glutathione content of colonic mucosa. Evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 1998; 43: 1088-95.
249. Sido B, Hack V, Hochlehnert A, et al. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 1998; 42: 485-92.
250. Miralles-Barrachina O, Savoye G, Belmonte-Zalar L. et al. Low levels of glutathlone in endoscopic biopsies of patients with Crohn's colitis: The role of malnutrition. Clin Nutr 1999; 18: 313-7.
251. Mulder TPJ, Verspaget HW, Janssens AR, et al. Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 1991; 32: 1146-50.
252. Sturniolo GC, Mestriner C, Lecis PE, et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 1998; 33: 644-9.
253. Brüwer M, Schmid KW, Metz KA, et al. Increased expression of metallothionein in inflammatory bowel disease. Inflamm Res 2001; 50: 289-93.
254. Dagli Ü, Balk M, Yücel D. et al. The role of reactive oxygen metabolites in ulcerative colitis. Inflamm Bowel Dis 1997; 3: 260-4.
255. Durak I, Yasa MH, Bektas A, et al. Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepato-Gastroenterology 2000; 47: 1015-7.
256. O'Morain C, Smethurst P, Levi AJ, et al. Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations. Gut 1984; 25: 455-9.
257. Aimone-Gastin I. Cable S. Keller JM, et al. Studies on peroxisomes of colonic mucosa in Crohn's disease. Dig Dis Sci 1994; 39: 2177-85.
258. Bhaskar L, Ramakrishna BS. Balasubramanian KA. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995; 10: 140-3.
259. Miles AM, Grisham MB. Antioxidant properties of amino-salicylates. Methods Enzymol 1994; 234: 555-72.
260. Salim AS. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: A new approach. J Lab Clin Med 1992; 119: 710-7.
261. Hammerschmidt DE, Gross AG. Allegations of impropriety in manuscripts by Aws S. Salim: Examination and withdrawal of journal aegis. The Executive Editorial Committee of the Journal of Laboratory and Clinical Medicine. J Lab Clin Med 1994; 123: 795-9.
262. Niwa Y, Somiya K, Michelson AM, et al. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Rad Res Commun 1985; 1: 137-53.
263. Emerit J, Pelletier S, Tosoni-Verlignue D, et al. Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. Free Rad Biol Med 1989; 7: 145-9.
264. Salvemini D, Riley DP, Cuzzocrea S. SOD mimetics are coming of age. Nat Rev Drug Disc 2002; 1: 367-74.